Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity

Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study

(2013) Tien Hoang et al.   INVESTIGATIONAL NEW DRUGS

Bortezomib inhibits proteasomal degradation of IκBα and induces mitochondrial dependent apoptosis in activated B-cell diffuse large B-cell lymphoma

(2013) Rong Bu et al.   LEUKEMIA & LYMPHOMA

Smac Mimetics in Combination with TRAIL Selectively Target Cancer Stem Cells in Nasopharyngeal Carcinoma

(2013) M.-s. Wu et al.   MOLECULAR CANCER THERAPEUTICS

Biological delivery approaches for gene therapy: Strategies to potentiate efficacy and enhance specificity

(2013) Elham Mohit et al.   MOLECULAR IMMUNOLOGY

XIAP as a Radioresistance Factor and Prognostic Marker for Radiotherapy in Human Rectal Adenocarcinoma

(2012) Driffa Moussata et al.   AMERICAN JOURNAL OF PATHOLOGY

Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism

(2012) Jennifer L. Allensworth et al.   BREAST CANCER RESEARCH AND TREATMENT

Suicide gene therapy in cancer: Where do we stand now?

(2012) Sónia Duarte et al.   CANCER LETTERS

XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer

(2012) Xi-Hu Yang et al.   PLoS One

Bortezomib Primes Neuroblastoma Cells for TRAIL-Induced Apoptosis by Linking the Death Receptor to the Mitochondrial Pathway

(2011) I. Naumann et al.   CLINICAL CANCER RESEARCH

X-linked inhibitor of apoptosis positive nuclear labeling: a new independent prognostic biomarker of breast invasive ductal carcinoma

(2011) Yutao Zhang et al.   Diagnostic Pathology

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

(2011) Antonio Di Stasi et al.   NEW ENGLAND JOURNAL OF MEDICINE

In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis

(2011) Ali Gholamrezanezhad et al.   NUCLEAR MEDICINE AND BIOLOGY

Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection

(2010) T. Jacobsen et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

(2010) Giulia Grisendi et al.   CANCER RESEARCH

An Inducible Caspase 9 Suicide Gene to Improve the Safety of Mesenchymal Stromal Cell Therapies

(2010) Carlos Almeida Ramos et al.   STEM CELLS

Stem cells as vectors for antitumour therapy

(2010) M. R Loebinger et al.   THORAX

Smac mimetics as new cancer therapeutics

(2009) Derrick J. Chen et al.   ANTI-CANCER DRUGS

Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells

(2009) T. Hideshima et al.   BLOOD

A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB

(2009) Yao Dai et al.   BMC CANCER

Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors

(2009) F Xu et al.   CANCER GENE THERAPY

Reduction of nontarget infection and systemic toxicity by targeted delivery of conditionally replicating viruses transported in mesenchymal stem cells

(2009) J L Dembinski et al.   CANCER GENE THERAPY

Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma

(2009) Peng Gao et al.   CANCER LETTERS

HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells

(2009) Miroslava Matuskova et al.   CANCER LETTERS

Human Bone Marrow-Derived Mesenchymal Stem Cells for Intravascular Delivery of Oncolytic Adenovirus  24-RGD to Human Gliomas

(2009) R. L. Yong et al.   CANCER RESEARCH

Magnetic Resonance Imaging of Mesenchymal Stem Cells Homing to Pulmonary Metastases Using Biocompatible Magnetic Nanoparticles

(2009) M. R. Loebinger et al.   CANCER RESEARCH

Histocompatibility testing of cultivated human bone marrow stromal cells – A promising step towards pre-clinical screening for allogeneic stem cell therapy

(2009) Purushotham Reddy Koppula et al.   CELLULAR IMMUNOLOGY

A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study

(2009) Carol Aghajanian et al.   GYNECOLOGIC ONCOLOGY

Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system

(2009) C. Foti et al.   MOLECULAR CANCER THERAPEUTICS

Mechanisms of proteasome inhibitor action and resistance in cancer

(2008) David J. McConkey et al.   DRUG RESISTANCE UPDATES

Quantitative Analysis of Pathways Controlling Extrinsic Apoptosis in Single Cells

(2008) John G. Albeck et al.   MOLECULAR CELL

Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect

(2008) Uwe M. Fischer et al.   STEM CELLS AND DEVELOPMENT

Mesenchymal Stem Cells: An Emerging Tool for Cancer Targeting and Therapy

(2008) Vanessa Fritz et al.   Current Stem Cell Research & Therapy